TherapeuticsMD (TXMD) Current Deferred Revenue (2012 - 2014)

TherapeuticsMD (TXMD) has reported Current Deferred Revenue for 3 consecutive years, with $522613.0 the latest figure, recorded in Q4 2014.

• For the quarter ending Q4 2014, Current Deferred Revenue fell 67.39% year-over-year to $522613.0; the trailing twelve-month figure through Dec 2014 stood at $522613.0 (down 67.39% YoY), and the FY2014 full-year result was $522613.0, down 67.39% from the prior year.
• Current Deferred Revenue eased to $522613.0 in Q4 2014 per TXMD's latest filing, from $1.6 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.6 million in Q4 2013 and bottomed at $522613.0 in Q4 2014.
• Historically, Current Deferred Revenue has averaged $955520.7 across 3 years, with a median of $922151.0 in 2012.
• The sharpest annual moves came in 2013 and 2014: Current Deferred Revenue jumped 39.99% in 2013, then slumped 67.39% in 2014.
• Over 3 years, Current Deferred Revenue stood at $1.1 million in 2012, then soared by 39.99% to $1.6 million in 2013, then plunged by 67.39% to $522613.0 in 2014.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $522613.0, $1.6 million, and $1.1 million for Q4 2014, Q4 2013, and Q1 2013 respectively.